Increasing evidence has also shown that Sp1 and Sp3 are expressed at higher levels in a number of cancer cells than in normal cells, and knockdown of Sp1 or Sp3 in cancer cells dramatically reduced tumorigenic and metastatic phenotypes (50). This evidence concerns the gene SP1 and cancer.